(LEN-B) Lennar - Ratings and Ratios
Homes, Residential Land, Multifamily Properties, Mortgage Financing
LEN-B EPS (Earnings per Share)
LEN-B Revenue
Description: LEN-B Lennar
Lennar Corporation is a leading US homebuilder operating primarily under the Lennar brand, with a diversified business model spanning single-family home construction, multifamily rental properties, and financial services. The companys homebuilding operations involve constructing and selling single-family attached and detached homes, as well as purchasing, developing, and selling residential land.
To evaluate Lennars performance, key metrics to consider include revenue growth, gross margin, and return on equity (ROE). With a reported ROE of 15.56%, Lennar demonstrates a relatively strong return on shareholder equity. Additionally, the companys diversified business segments, including Financial Services and Multifamily, contribute to its overall revenue stream and help mitigate potential risks associated with the cyclical nature of the homebuilding industry.
From a valuation perspective, Lennars price-to-earnings (P/E) ratio of 9.01 suggests a relatively attractive valuation compared to its earnings. However, the forward P/E ratio of 12.52 indicates expected earnings growth. To further assess the companys valuation, metrics such as enterprise value-to-EBITDA (EV/EBITDA) and price-to-book (P/B) ratio can be considered.
Lennars business model is also influenced by its ability to manage land inventory, construction costs, and interest rates. The companys focus on serving various customer segments, including first-time, move-up, active adult, and luxury homebuyers, allows it to adapt to changing market conditions. By examining key performance indicators (KPIs) such as homebuilding gross margin, average sales price, and community count, investors can gain insights into Lennars operational efficiency and growth prospects.
LEN-B Stock Overview
| Market Cap in USD | 35,182m |
| Sub-Industry | Homebuilding |
| IPO / Inception | 2003-04-23 |
LEN-B Stock Ratings
| Growth Rating | 28.3% |
| Fundamental | 53.1% |
| Dividend Rating | 65.6% |
| Return 12m vs S&P 500 | -33.2% |
| Analyst Rating | - |
LEN-B Dividends
| Dividend Yield 12m | 1.60% |
| Yield on Cost 5y | 3.57% |
| Annual Growth 5y | 26.19% |
| Payout Consistency | 94.3% |
| Payout Ratio | 16.6% |
LEN-B Growth Ratios
| Growth Correlation 3m | 93.1% |
| Growth Correlation 12m | -64% |
| Growth Correlation 5y | 81.6% |
| CAGR 5y | 33.17% |
| CAGR/Max DD 3y | 0.80 |
| CAGR/Mean DD 3y | 5.20 |
| Sharpe Ratio 12m | -0.56 |
| Alpha | 0.00 |
| Beta | 0.982 |
| Volatility | 34.09% |
| Current Volume | 39.5k |
| Average Volume 20d | 37k |
| Stop Loss | 123.6 (-3.1%) |
| Signal | -0.20 |
Piotroski VR‑10 (Strict, 0-10) 5.0
| Net Income (3.26b TTM) > 0 and > 6% of Revenue (6% = 2.12b TTM) |
| FCFTA 0.01 (>2.0%) and ΔFCFTA -9.46pp (YES ≥ +1.0pp, WARN ≥ +0.5pp) |
| NWC/Revenue 48.96% (prev 72.88%; Δ -23.91pp) (YES ≤20% & Δ≤-1pp; WARN ≤25% & Δ≤0 oder ≤40% & Δ≤-3pp) |
| CFO/TA 0.01 (>3.0%) and CFO 409.7m <= Net Income 3.26b (YES >=105%, WARN >=100%) |
| Net Debt (2.80b) to EBITDA (3.44b) ratio: 0.82 <= 3.0 (WARN <= 3.5) |
| Current Ratio 9.15 (target 1.5–3.0; WARN 1.2–<1.5 or >3.0–5.0; CFO/TA gate active) |
| Outstanding Shares last Quarter (261.5m) change vs 12m ago -4.45% (target <= -2.0% for YES) |
| Gross Margin 13.27% (prev 41.96%; Δ -28.69pp) >=18% & Δ>=+0.5pp (WARN >=15% & Δ>=0) |
| Asset Turnover 96.85% (prev 92.52%; Δ 4.33pp) >=50% & Δ>=+2pp (WARN >=35% & Δ>=0) |
| Interest Coverage Ratio 21.34 (EBITDA TTM 3.44b / Interest Expense TTM 156.6m) >= 6 (WARN >= 3) |
Altman Z'' 7.93
| (A) 0.50 = (Total Current Assets 19.45b - Total Current Liabilities 2.13b) / Total Assets 34.37b |
| (B) 0.63 = Retained Earnings (Balance) 21.65b / Total Assets 34.37b |
| (C) 0.09 = EBIT TTM 3.34b / Avg Total Assets 36.52b |
| (D) 1.86 = Book Value of Equity 21.68b / Total Liabilities 11.64b |
| Total Rating: 7.93 = (6.56 * A) + (3.26 * B) + (6.72 * C) + (1.05 * D) |
ValueRay F-Score (Strict, 0-100) 53.09
| 1. Piotroski 5.0pt = 0.0 |
| 2. FCF Yield 0.70% = 0.35 |
| 3. FCF Margin 0.79% = 0.20 |
| 4. Debt/Equity 0.28 = 2.46 |
| 5. Debt/Ebitda 1.84 = 0.31 |
| 6. ROIC - WACC (= 0.56)% = 0.70 |
| 7. RoE 12.95% = 1.08 |
| 8. Rev. Trend 4.65% = 0.35 |
| 9. EPS Trend -46.93% = -2.35 |
What is the price of LEN-B shares?
Over the past week, the price has changed by -2.69%, over one month by +1.35%, over three months by +22.40% and over the past year by -20.71%.
Is Lennar a good stock to buy?
Based on momentum, paid dividends and discounted-cash-flow analyses, the fair value of LEN-B is around 138.54 USD . This means that LEN-B is currently overvalued and has a potential downside of 8.64%.
Is LEN-B a buy, sell or hold?
What are the forecasts/targets for the LEN-B price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | - | - |
| Analysts Target Price | - | - |
| ValueRay Target Price | 154.1 | 20.9% |
Last update: 2025-09-12 04:40
LEN-B Fundamental Data Overview
CCE Cash And Equivalents = 1.45b USD (Cash And Short Term Investments, last quarter)
P/E Trailing = 10.8143
P/E Forward = 13.0378
P/S = 0.9946
P/B = 1.4961
P/EG = 2.0522
Beta = 1.348
Revenue TTM = 35.37b USD
EBIT TTM = 3.34b USD
EBITDA TTM = 3.44b USD
Long Term Debt = 4.21b USD (from longTermDebt, last quarter)
Short Term Debt = 2.13b USD (from totalCurrentLiabilities, last quarter)
Debt = 6.33b USD (Calculated: Short Term 2.13b + Long Term 4.21b)
Net Debt = 2.80b USD (from netDebt column, last quarter)
Enterprise Value = 40.07b USD (35.18b + Debt 6.33b - CCE 1.45b)
Interest Coverage Ratio = 21.34 (Ebit TTM 3.34b / Interest Expense TTM 156.6m)
FCF Yield = 0.70% (FCF TTM 278.7m / Enterprise Value 40.07b)
FCF Margin = 0.79% (FCF TTM 278.7m / Revenue TTM 35.37b)
Net Margin = 9.20% (Net Income TTM 3.26b / Revenue TTM 35.37b)
Gross Margin = 13.27% ((Revenue TTM 35.37b - Cost of Revenue TTM 30.68b) / Revenue TTM)
Tobins Q-Ratio = 1.85 (Enterprise Value 40.07b / Book Value Of Equity 21.68b)
Interest Expense / Debt = 0.59% (Interest Expense 37.2m / Debt 6.33b)
Taxrate = 23.48% (1.22b / 5.18b)
NOPAT = 2.56b (EBIT 3.34b * (1 - 23.48%))
Current Ratio = 9.15 (Total Current Assets 19.45b / Total Current Liabilities 2.13b)
Debt / Equity = 0.28 (Debt 6.33b / last Quarter total Stockholder Equity 22.58b)
Debt / EBITDA = 1.84 (Net Debt 2.80b / EBITDA 3.44b)
Debt / FCF = 22.73 (Debt 6.33b / FCF TTM 278.7m)
Total Stockholder Equity = 25.15b (last 4 quarters mean)
RoA = 9.47% (Net Income 3.26b, Total Assets 34.37b )
RoE = 12.95% (Net Income TTM 3.26b / Total Stockholder Equity 25.15b)
RoCE = 11.39% (Ebit 3.34b / (Equity 25.15b + L.T.Debt 4.21b))
RoIC = 8.79% (NOPAT 2.56b / Invested Capital 29.10b)
WACC = 8.23% (E(35.18b)/V(41.52b) * Re(9.63%)) + (D(6.33b)/V(41.52b) * Rd(0.59%) * (1-Tc(0.23)))
Shares Correlation 3-Years: -100.00 | Cagr: -0.88%
Discount Rate = 9.63% (= CAPM, Blume Beta Adj.)
[DCF Debug] Terminal Value 71.74% ; FCFE base≈1.76b ; Y1≈1.66b ; Y5≈1.59b
Fair Price DCF = 691.2 (DCF Value 21.71b / Shares Outstanding 31.4m; 5y FCF grow -6.74% → 3.0% )
EPS Correlation: -46.93 | EPS CAGR: -31.04% | SUE: -0.46 | # QB: 0
Revenue Correlation: 4.65 | Revenue CAGR: -7.48% | SUE: N/A | # QB: None
Additional Sources for LEN-B Stock
Tweets: X | Stocktwits
Fund Manager Positions: Dataroma | Stockcircle